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Introduction 
 
The first report of soy being administered to an 
infant is over 100 years old.1 Since the 1960s the 
composition of soy formula has been better adapted 
to the nutritional needs of infants and since 2000 
infant formula based on soy fulfils European 
Directives and legislation for infant feeding. 
Soy infant formula contains a soy protein 
isolate (95% protein), and methionine, carnitine, 
taurine, iron, calcium phosphor and zinc are added. 
Heating destroys the anti-protease activity of soy for 
over 90 %. In 2016, soy infant formula was still 12% 
of the USA market and 25 % of infants were fed soy 
infant formula during their first years of life.2  
In 2006, ESPGHAN published a consensus 
statement regarding soy infant formula: i) soy 
protein formula can be used for feeding term infants, 
but they have no nutritional advantage over cows' 
milk protein formula and contain high 
concentrations of phytate, aluminium, and  
 
 
 
phyto-estrogens (isoflavones), which might have 
untoward effects; ii) there are no data to support the 
use of soy protein formulae in preterm infants; iii) 
indications for soy protein formula include severe 
persistent lactose intolerance, galactosemia, and 
ethical considerations (e.g., vegan concepts); iv) soy 
protein formula have no role in the prevention of 
allergic diseases and should not be used in infants 
with food allergy during the first 6 months of life; v) 
if soy protein formula are considered for therapeutic 
use in food allergy after the age of 6 months because 
of their lower cost and better acceptance, tolerance 
to soy protein should first be established by clinical 
challenge.3 The cut-off age of 6 months was debated 
and tended to be followed, although based on weak 
scientific evidence. 
According to a review by Katz et al,7 based 
on the information obtained out of 40 studies 
identified, the established weighted prevalence of 
soy allergies is 0 to 0.5 % (0.27) for the general 
population, 0.4 to 3.1 % (1.9) for the referred 
population, and 0 to 12.9 % (2.7) for allergic 
children. The prevalence of sensitization after the 
use of soy infant formula is 8.7 and 8.8 %, 
depending on the method used.7 According to this 
review, there is no difference according to the age of 
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6 months. A recently published Mexican consensus 
paper confirmed the statements of the AAP and 
concluded that there was no safety issue with soy 
infant formula.8 Soy infant formulas have important 
advantages in terms of cost-benefit, palatability and 
effects on the intestinal microbiota, compared to 
other formulas.8 Although evidence to recommend 
its use in functional digestive disorders is limited, 
soy infant formulas have an adequate safety profile 
and are a valid option for infant feeding.8 
Infants fed soy infant formula have a normal 
growth.9 Lactose-free formula has been 
recommended in the re-alimentation of an infectious 
gastroenteritis after failure of lactose-containing re-
alimentation.5 Lactose-free re-alimentation results 
in a decreased need for hospitalization according to 
data from Thailand.10  
Anthropometric patterns of children fed soy 
infant formula are similar to those of children fed 
cow's milk formula or human milk.11 Despite the 
high levels of phytates and aluminium in soy 
formula, haemoglobin, serum protein, zinc and 
calcium concentrations and bone mineral content 
were found to be similar to those of children fed 
cow's milk formula or human milk.11  
Soy formulae used to contain phytates which 
were blamed for their chelating capacity, preventing 
the proper absorption of micronutrients.12 Today, 
however, phytates are almost totally removed from 
the soy formulae.12 
The levels of genistein and daidzein to be 
higher in children fed soy infant formula; however, 
no strong evidence for a negative effect on 
reproductive and endocrine functions was found.11 
Immune measurements and neurocognitive 
parameters were similar in all the feeding groups.11 
Phyto-estrogens are plant compounds with 
estrogenic activity. Those contained in soy formula 
(SF) are of the isoflavone class and include, in order 
of quantitative and biological importance, genistein, 
daidzein, and glycitein.13 All have a molecular 
structure quite similar to that of the human female 
hormone 17-β-oestradiol and, consequently, have 
estrogenic activity, even if 1,000–10,000 times 
lower.13 They are present in very large amounts in 
soy formula, although with differences among 
commercial preparations. It has been calculated that 
the mean daily intake of isoflavones by an infant 
exclusively fed with one of the presently marketed 
soy formula can be as high as 11 mg/kg body weight, 
an amount significantly higher than that necessary to 
exert hormone-like effects in adults.13,14 According 
to other data from literature, the isoflavone intake of 
an infant fed breastmilk or cow milk formula is 
0.005–0.01 mg/d, while with soy infant formula 
amounts of 6–47 mg/day are reached.15 This intake 
is similar to the daily intake by an adult with a 
standard Asian diet (8–50 mg/d) or vegan diet (15–
60 mg/day), while vegetarians have a lower intake 
(3–12 mg/day).15 A standard Western diet has an 
isoflavone content of 0.5 – 3.5 mg/day.15  
A global evaluation of the impact of modern 
soy formula on human development seems to 
suggest that their use is not associated with relevant 
abnormalities.13 The negative influence of 
isoflavones, which has been repeatedly 
demonstrated in developing animals, has not been 
evidenced with the same relevance in humans. Only 
children with congenital hypothyroidism can have 
problems and require re-modulation of thyroid 
hormone replacement doses. The potential harmful 
effects of soy isoflavones on child development 
cannot be definitively excluded.13 The consumption 
of soy-based infant formula is not associated with 
early onset of puberty.16 Relative to girls fed with 
cow-milk formula, those fed with soy formula 
demonstrated tissue and organ-level developmental 
trajectories consistent with response to exogenous 
estrogen exposure.17 However, these effects seem to 
be transitory as no early infant feeding effects were 
found on reproductive organs volumes and structural 
characteristics in children age 5 years.18 
The other concern to take into consideration 
is the use of transgenic soy in formulas.12 The US 
Department of Agriculture records that up to 93% of 
soybean crops are transgenic.12 Adverse effects of 
transgenic soy were never reported.  
The addition of fiber offers an additional 
benefit in infants and young children with 
constipation. About 10 % of all infants and young 
children are constipated.19 Although all functional 
gastro-intestinal disorders are considered as separate 
entities, over 75 % of the infants present with a 
combination of functional disorders.20 Fibers lead to 
an increase of bowel movements and improve stool 
consistency.21 Fiber has a significantly improved 
success rate compared to placebo.21 Prebiotic 
oligosaccharides were shown to increase the 
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defecation frequency and to soften the stools.22,23 
The addition of oligo fructose regulates defecation 
irregularities associated with low fiber intake.24 A 
consistent prebiotic effect along with a decrease in 
pH and increase in %-bifidobacteria and %-
lactobacilli was found in a group administered 0.4 g 
inulin/100 mL.25 
  
Conclusion 
 
Soy infant formula is a valuable alternative for cow 
milk based infant formula, since nutritional safety 
and no long-term adverse effects were reported. The 
supplementation with fiber is effective in the 
management of constipation. 
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